Vrselja A, Latifi A, Baber RJ, Stuckey BGA, et al. Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2022;400:1704-1711.
PMID: 36366886